[EFFECTIVE TREATMENT FOR BULLOUS PEMPHIGOID WITH OMALIZUMAB].

Neumark, Michal; Tal, Yuval; Zlotogorski, Abraham; Molho-Pessach, Vered

Neumark, Michal; Tal, Yuval; Zlotogorski, Abraham; Molho-Pessach, Vered.

Afiliación

Neumark M; Department of Dermatology, Division of Internal Medicine, Hadassah Medical Center, Hebrew University, Faculty of Medicine, Jerusalem, Israel.
Tal Y; Clinical Immunology Unit, Division of Internal Medicine, Hadassah Medical Center, Hebrew University, Faculty of Medicine, Jerusalem, Israel.
Zlotogorski A; Department of Dermatology, Division of Internal Medicine, Hadassah Medical Center, Hebrew University, Faculty of Medicine, Jerusalem, Israel.
Molho-Pessach V; Department of Dermatology, Division of Internal Medicine, Hadassah Medical Center, Hebrew University, Faculty of Medicine, Jerusalem, Israel.

Harefuah ; 159(1): 29-30, 2020 Jan.

Article en He | MEDLINE | ID: mdl-31930804

Asunto(s)

Antialérgicos/uso terapéutico; Enfermedades Autoinmunes; Omalizumab/uso terapéutico; Penfigoide Ampolloso/tratamiento farmacológico; Anciano; Anticuerpos Monoclonales; Humanos; Masculino; Prednisona

Buscar en Google

Imprimir

XML

PubMed Links

Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedades Autoinmunes / Penfigoide Ampolloso / Antialérgicos / Omalizumab Límite: Aged / Humans / Male Idioma: He Revista: Harefuah Año: 2020 Tipo del documento: Article País de afiliación: Israel

Buscar en Google

Imprimir

XML

PubMed Links